AllianceBernstein’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Hold |
40,630
| – | – | ﹤0.01% | 2688 |
|
|
2025
Q1 | $270K | Hold |
40,630
| – | – | ﹤0.01% | 2826 |
|
|
2024
Q4 | $448K | Hold |
40,630
| – | – | ﹤0.01% | 2686 |
|
|
2024
Q3 | $499K | Hold |
40,630
| – | – | ﹤0.01% | 2665 |
|
|
2024
Q2 | $549K | Buy |
40,630
+3,290
| +9% | +$44.4K | ﹤0.01% | 2623 |
|
|
2024
Q1 | $504K | Hold |
37,340
| – | – | ﹤0.01% | 2585 |
|
|
2023
Q4 | $196K | Sell |
37,340
-3,980
| -10% | -$20.9K | ﹤0.01% | 2984 |
|
|
2023
Q3 | $163K | Hold |
41,320
| – | – | ﹤0.01% | 2994 |
|
|
2023
Q2 | $439K | Buy |
41,320
+6,520
| +19% | +$69.3K | ﹤0.01% | 2706 |
|
|
2023
Q1 | $290K | Buy |
34,800
+4,400
| +14% | +$36.7K | ﹤0.01% | 2787 |
|
|
2022
Q4 | $281K | Buy |
30,400
+2,900
| +11% | +$26.8K | ﹤0.01% | 2897 |
|
|
2022
Q3 | $353K | Buy |
27,500
+3,800
| +16% | +$48.8K | ﹤0.01% | 2791 |
|
|
2022
Q2 | $313K | Buy |
23,700
+3,900
| +20% | +$51.5K | ﹤0.01% | 2859 |
|
|
2022
Q1 | $417K | Hold |
19,800
| – | – | ﹤0.01% | 2743 |
|
|
2021
Q4 | $475K | Buy |
19,800
+1,200
| +6% | +$28.8K | ﹤0.01% | 2759 |
|
|
2021
Q3 | $473K | Sell |
18,600
-1,200
| -6% | -$30.5K | ﹤0.01% | 2767 |
|
|
2021
Q2 | $666K | Buy |
19,800
+1,700
| +9% | +$57.2K | ﹤0.01% | 2682 |
|
|
2021
Q1 | $703K | Buy |
18,100
+700
| +4% | +$27.2K | ﹤0.01% | 2529 |
|
|
2020
Q4 | $1.08M | Sell |
17,400
-3,300
| -16% | -$204K | ﹤0.01% | 2253 |
|
|
2020
Q3 | $693K | Sell |
20,700
-1,200
| -5% | -$40.2K | ﹤0.01% | 2346 |
|
|
2020
Q2 | $522K | Buy |
21,900
+4,600
| +27% | +$110K | ﹤0.01% | 2571 |
|
|
2020
Q1 | $396K | Buy |
+17,300
| New | +$396K | ﹤0.01% | 2463 |
|